Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xoma Royalty Corporation 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 USA

www.xoma.com Employees: 13 P: 510-204-7200

Sector:

Medical

Description:

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 301,526
Enterprise Value, $K 316,866
Shares Outstanding, K 12,383
Float, K 11,256
% Float 90.90%
Short Interest, K 1,051
Short Float 8.49%
Days to Cover 1.34
Short Volume Ratio 0.71
% of Insider Shareholders 9.10%
% of Institutional Shareholders 95.92%

Financials:

Annual Sales, $ 28,490 K
Annual Net Income, $ -13,820 K
Last Quarter Sales, $ 9,350 K
Last Quarter Net Income, $ 14,050 K
EBIT, $ 4,230 K
EBITDA, $ 4,450 K

Growth:

1-Year Return -3.10%
3-Year Return 12.73%
5-Year Return -32.73%
5-Year Revenue Growth 55.09%
5-Year Earnings Growth -1,634.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 11/12/25
Next Earnings Date 03/16/26 [--]
Earnings Per Share ttm -0.27
EPS Growth vs. Prev Qtr -172.92%
EPS Growth vs. Prev Year 10.26%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/18/16

XOMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 39.04
Price/Earnings to Growth N/A
Return-on-Equity % 2.91%
Return-on-Assets % 1.03%
Profit Margin % -48.51%
Debt/Equity 1.01
Price/Sales 31.92
Price/Cash Flow N/A
Price/Book 3.30
Book Value/Share 8.93
Interest Coverage -0.41
60-Month Beta 0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar